Abstract
Regulation of β2-adrenergic receptor (β2AR) levels by glucocorticoids is a physiologically important mechanism for altering β2AR responsiveness. Glucocorticoids increase β2AR density by increasing the rate of β2AR gene transcription, but the cis-elements involved have not been well characterized. We now show that one of six potential glucocorticoid response elements (GREs) in the 5′-flanking region of the rat β2AR gene is necessary for glucocorticoid-dependent stimulation of receptor gene expression. Using a nested set of deletion fragments of the rat β2AR gene 5′-flanking region fused to a luciferase reporter gene, glucocorticoid-dependent induction of reporter gene expression in HepG2 cells was localized to a region between positions −643 and −152, relative to the transcription initiation site. In electrophoretic mobility shift assays, a double-stranded oligonucleotide incorporating a near-consensus GRE from this region (positions −379 to −365) formed complexes with the human recombinant glucocorticoid receptor, as well as with nuclear protein from dexamethasone-treated HepG2 cells. Mutation of a single base within this GRE sequence greatly diminished interaction of the mutated oligonucleotide with the human recombinant glucocorticoid receptor. The functional activity of the GRE was characterized using a luciferase reporter construct driven by a minimal thymidine kinase promoter. In HepG2 cells transfected with constructs containing the GRE, dexamethasone increased reporter gene expression approximately 3-fold, whereas a dexamethasone effect was not observed with constructs lacking the GRE. Taken together, these findings show that a GRE located at positions −379 to −365 in the 5′-flanking region of the rat β2AR gene mediates glucocorticoid stimulation of β2AR gene transcription.
Footnotes
- Received August 6, 1998.
- Accepted September 11, 1998.
-
Send reprint requests to: Dr. Lawrence E. Cornett, Department of Physiology and Biophysics, Slot 750, University of Arkansas for Medical Sciences, 4301 West Markham Street, Little Rock, AR 72205. E-mail:cornettlawrencee{at}exchange.uams.edu
-
This work was supported in part by National Institutes of Health Grant R01-GM30669.
- The American Society for Pharmacology and Experimental Therapeutics
MolPharm articles become freely available 12 months after publication, and remain freely available for 5 years.Non-open access articles that fall outside this five year window are available only to institutional subscribers and current ASPET members, or through the article purchase feature at the bottom of the page.
|